Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated basis) for quarter and half year ended on 30th September, 2025